Campylobacter infections, primarily caused by Campylobacter jejuni and Campylobacter coli bacteria, are a common source of bacterial gastroenteritis worldwide. These bacteria are often transmitted to humans through the consumption of contaminated food, particularly undercooked poultry, unpasteurized milk, and contaminated water. Symptoms of Campylobacter infections include diarrhea, abdominal cramping, fever, and nausea. The infection is usually self-limiting, but in severe cases, it may lead to complications such as Guillain-Barré syndrome, a rare neurological disorder. Diagnosis involves stool culture and microbiological tests to identify Campylobacter bacteria. Hydration and, in some cases, antibiotic therapy may be recommended for severe infections or those with certain risk factors. Preventive measures include thorough cooking of poultry and other meats, pasteurization of milk, and practicing good food safety and hygiene. Avoiding untreated water and ensuring proper handwashing are also essential in preventing Campylobacter infections. Given its widespread occurrence and potential complications, Campylobacter infections highlight the importance of safe food handling practices and public health measures to reduce the risk of transmission and associated health complications.
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Lara Isis Teodoro
Mayo Clinic, United States
Ahmed Abdulazeez
BHRUT Trust, United Kingdom
Elena Chiappini
University of Florence, ItalySubmit your abstract Today
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States